Arterial Catheter Control System for Automated Blood Flow Reversal

The control system continuously monitors physical parameters (such as pressure, flow rate, or other physiological indicators) and uses this feedback to automatically adjust balloon inflation and deflation timing. The processor receives signals representing physical parameters and automatically modifies the blood flow reversal protocol based on real-time patient condition changes, eliminating the need for constant manual intervention while maintaining treatment flexibility.

The system is designed to autonomously manage the blood flow reversal protocol by automatically detecting when parameter thresholds are met and executing相应的 balloon inflation/deflation sequences. The control system serves itself by making real-time decisions based on monitored parameters, reducing operator workload while maintaining protocol adaptability through automated adjustment mechanisms.

The control system transitions from static, pre-programmed timing to dynamic, real-time adjustment of balloon deflation based on monitored physical parameters. The processor continuously evaluates patient condition data and automatically modifies deflation timing to optimize therapeutic outcomes, allowing the protocol to adapt to changing physiological conditions while maintaining structured control through automated decision-making algorithms.

The system incorporates continuous monitoring of physical parameters with automatic feedback loops that adjust balloon operation timing based on real-time patient response. When parameters indicate improved or deteriorated conditions, the system automatically modifies the blood flow reversal protocol, ensuring both consistency in monitoring and adaptability in response to actual patient needs.

The patent replaces complex manual mechanical control systems with automated electronic control based on physical parameter monitoring. The processor-based system automatically interprets sensor data and executes balloon control sequences, substituting manual judgment and mechanical operation with electronic sensing and automated actuation, thereby reducing operational complexity while enhancing adaptability to patient conditions.

The control system performs self-monitoring and self-adjustment based on predefined parameter thresholds and automated decision logic. By embedding the control intelligence within the system itself, the complexity of real-time decision-making is handled autonomously by the device, reducing the burden on operators while maintaining high adaptability to changing patient conditions through automated response mechanisms.

The control system continuously monitors physical parameters during balloon inflation and automatically detects when therapeutic goals are achieved or when adverse effects begin to manifest. Based on this real-time feedback, the system automatically terminates inflation at the optimal moment, preventing both under-treatment and over-treatment. This ensures maximum therapeutic benefit while minimizing duration-related adverse effects through automated, parameter-based control.

The system dynamically adjusts balloon inflation duration based on real-time patient response rather than using fixed time intervals. The processor continuously evaluates physiological parameters and automatically modifies inflation timing to achieve optimal therapeutic effect, allowing the treatment duration to be optimized for each patient's specific response pattern while automatically preventing excessive duration that could lead to adverse effects.